Wendy Song

Wendy Song, CFA, currently serves as the Director of Investor Relations and Financial Strategy at Innovent Biologics since July 2020. Prior to this role, Wendy was an Equity Research Analyst focusing on the healthcare sector at UBS Securities Co., Ltd from April 2015 to July 2020, where Wendy contributed to a team recognized as the #2 ranked in healthcare in the latest China II rankings. Wendy's earlier experience includes positions in controlling and finance at Siemens and internships in commercial finance at GE Capital and investment management at Citi. Wendy holds a Master of Science in Finance from the University of Maryland - Robert H. Smith School of Business and a Bachelor of Science in Finance from Tongji University.